70771-1905 Dasatinib - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

70771-1905

Brand Name:

Dasatinib

Generic Name:

Dasatinib

Dosage Form Name:

TABLET

Administration Route:

Oral

Substances:

Name: DASATINIB

Strength: 100.0

Unit: mg/1

Packages:

Code: 70771-1905-03

Description: 30 TABLET in 1 BOTTLE (70771-1905-3)

Effective Date: March 3, 2025

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

BCR-ABL

Orphan Drug Designation:

Status:

In Use